The company is closely monitoring the situation in New Zealand with regard to COVID-19. In the event of any significant developments, the company may, in its sole discretion, elect to hold the ASM as an online only meeting if it considers there are potential risks to the health of meeting attendees or if an in-person meeting is prohibited by law. In such circumstances, the company will provide shareholders with as much notice as is reasonably practicable by way of an announcement to the NZX and ASX and on the company's website at www.fphcare.com/asm.
Notice of the ASM will be released to the NZX and ASX, along with instructions for attending the virtual meeting, at least 20 working days prior to the meeting.
For more information about the company visit our website www.fphcare.com.
About Fisher & Paykel Healthcare
Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company's products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Ends
Contact
Attachments
- Original document
- Permalink
Disclaimer
Fisher & Paykel Healthcare Corporation Ltd. published this content on 04 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 June 2021 08:30:00 UTC.